Cervical Cancer Survivors Frequently Suffer From Long-Term Side Effects of Treatment

According to a new study around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia fatigue or hot flushes1 Cervical cancer affects more than 500000 women around the world each year with an average age [...]

Alternative Medicine Used Alone Appears to Reduce Survival Rates in Cancer Patients

Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death according to researchers from the Cancer Outcomes Public Policy and Effectiveness Research Center at Y [...]

Head and Neck Cancer-What You Need to Know

Head and neck cancer includes a number of different malignant cancers that develop in or around the throat larynx voice box nose sinuses and mouth Globally head and neck cancer is the seventh most common type of cancer with an estimated 400000-600000 diag [...]

FDA Approves IDHIFA A new Targeted Treatment for Acute Myeloid Leukemia

The US Food and Drug Administration today approved Idhifa enasidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia AML who have a specific genetic mutation The drug is approved for use with a companion diagnostic t [...]

Acalabrutinib granted Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma

The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for acalabrutinib for the treatment of patients with mantle cell lymphoma MCL who have received at least one prior therapy Acalabrutinib is a highly-selective potent Brut [...]

Roadmap to Personalized Therapies for Sarcoma and other Aggressive Cancers

Sarcoma is a rare and deadly form of cancer occurring in the bones and connective tissue that affects individuals of all ages Its aggressiveness rarity and diversity continue to hinder efforts to identify effective therapies for people with this malignanc [...]

FDA Approves Vyxeos for Adults with Poor Prognosis AML

The US Food and Drug Administration granted regular approval to a liposome-encapsulated combination of daunorubicin and cytarabine for the treatment of adults with newly-diagnosed therapy-related AML t-AML or AML with myelodysplasia-related changes AML-MR [...]

Pediatric MATCH Trial to Test Targeted Drugs in Childhood Cancers

Today investigators at the National Cancer Institute NCI and the Childrens Oncology Group COG announced the opening of enrollment for a unique precision medicine clinical trial NCI-COG Pediatric Molecular Analysis for Therapy Choice Pediatric MATCH is a n [...]

Nipple-Sparing Mastectomy Has Low Rate of Breast Cancer Recurrence

Investigators say most women with breast cancer are eligible for this type of mastectomy which leaves the natural nipple in place Women with breast cancer who undergo nipple-sparing mastectomy NSM have a low rate of the cancer returning within the first f [...]

Balance and Gait is Negatively Impacted By Chemotherapy Treatment

A single chemotherapy treatment can result in a significant negative impact on walking gait and balance putting patients at an increasing risk for falls according to a new study involving breast cancer patients conducted by researchers at The Ohio State U [...]